News Search Results
Aug 11, 2025, 15:20 ET Aquaporin lowers revenue guidance for 2025, but maintains EBITDA guidance, and initiates strategic review
Aquaporin A/S (ticker: AQP) ("Aquaporin" or the "Company"), an innovative water technology company dedicated to rethinking water filtration with biotechnology, today announces, pursuant to the Market Abuse Regulation on publication of inside information, that the Company is lowering its revenue guidance
More news about: Aquaporin A/S
Aug 11, 2025, 12:00 ET The Galien Foundation Announces 2025 Prix Galien USA Nominees for "Best Biotechnology Product," "Best Pharmaceutical Product" and "Best Product for Rare/Orphan Diseases"
dedicated to honoring innovators in life sciences, today announced the 2025 Prix Galien USA Award nominees for "Best Biotechnology Product," "Best Pharmaceutical Product," and "Best Product for Rare/Orphan Disease." Winners will be announced during the Prix Galien USA
More news about: The Galien Foundation
Aug 11, 2025, 12:00 ET Ajit Singh Appointed CEO of Harbinger Health and CEO-Partner of Flagship Pioneering
Aug. 11, 2025 /PRNewswire/ -- Flagship Pioneering, the bioplatform innovation company, and Harbinger Health, a biotechnology company pioneering the detection of early cancer, today announced the appointment of Ajit Singh, Ph.D. as CEO-Partner
More news about: Flagship Pioneering
Aug 11, 2025, 10:01 ET Next-Generation Solar Cell Market to Soar to US$12.95 Billion by 2031, Driven by Rising Solar Installations and Renewable Energy Investments - The Insight Partners
syndicated and consulting research services. We specialize in semiconductor and electronics, aerospace and defense, automotive and transportation, biotechnology, healthcare IT, manufacturing and construction, medical devices, technology, media and telecommunications, and chemicals and materials. Contact
More news about: The Insight Partners
Aug 11, 2025, 10:00 ET Pomerantz Law Firm Announces the Filing of a Class Action Against 3D Systems Corporation and Certain Officers - DDD
Medicine Program focuses on "the use of additive manufacturing for human organ transplantation." Since 2018, 3D Systems has partnered with the biotechnology company United Therapeutics Corporation ("United") "with a long-term goal of developing the capability to 3D print lungs that will allow patients
More news about: Pomerantz LLP
Aug 11, 2025, 09:30 ET AGEBOX Presents iKids-Growth: Pioneering Safe and Natural Support for Children's Height Development
This product is not intended to diagnose, treat, cure, or prevent any disease. About AGEBOX AGEBOX Inc. is a U.S.-based biotechnology company that develops evidence-based dietary supplements to support children's growth, cognition, and metabolic health. The company's proprietary
More news about: AGEBOX
Aug 11, 2025, 09:06 ET Caliber Enters 25th Year of Empowering Global Pharma with GxP Digital Solutions
With over two decades of expertise, Caliber has helped pharmaceutical and biotechnology companies in 17 countries enhance quality systems, streamline operations, and ensure regulatory compliance. To mark this milestone, Caliber
More news about: Caliber Technologies
Aug 11, 2025, 08:58 ET Caliber Enters 25th Year of Empowering Global Pharma with GxP Digital Solutions
With over two decades of expertise, Caliber has helped pharmaceutical and biotechnology companies in 17 countries enhance quality systems, streamline operations, and ensure regulatory compliance. To mark this milestone, Caliber
More news about: Caliber Technologies
Aug 11, 2025, 08:30 ET Enhancing Patient Recruitment in Clinical Research: A Personalized and Engaged Journey, Upcoming Webinar Hosted by Xtalks
the global life science, food, healthcare and medical device communities. Every year, thousands of industry practitioners (from pharmaceutical, biotechnology, food, healthcare and medical device companies, private & academic research institutions, healthcare centers, etc.) turn to Xtalks for access
More news about: Xtalks
Aug 11, 2025, 08:05 ET Data Published in The Laryngoscope shows INO-3107 Resulted in Long-Term Surgery Reduction in Recurrent Respiratory Papillomatosis (RRP)
MEETING, Pa., Aug. 11, 2025 /PRNewswire/ -- INOVIO (NASDAQ: INO), a biotechnology company focused on developing and commercializing DNA medicines to help treat and protect people from HPV-related diseases, cancer, and infectious
More news about: INOVIO Pharmaceuticals, Inc.
Aug 11, 2025, 08:00 ET 180 Life Sciences Announces Closing of Private Offering of Approximately $156 Million of Convertible Notes
assets per the terms of the Convertible Notes, and to continue its current iGaming operations, as well as continuing to seek to monetize its legacy biotechnology intellectual property. Advisors Clear Street LLC acted as financial advisor and exclusive placement agent for the Convertible
More news about: 180 Life Sciences Corp.
Aug 11, 2025, 08:00 ET AMI Pharm Advances AYP-101 to Phase 3, Paving the Way for a New Era in Fat-Reduction Injectable drugs
Aug. 11, 2025 /PRNewswire/ -- AMI Pharm, a biotechnology company specializing in next-generation aesthetic solutions, today announced that its lead drug candidate, AYP-101, has entered a pivotal
More news about: AMI Pharm
Aug 11, 2025, 05:19 ET Kexing Biopharm Enters Strategic Partnership with IQVIA to Accelerate Global Expansion
dedicated to building cutting-edge biotechnology platforms for new protein, new antibody, nucleic acid and other drugs. Adhering to the platform driven development model of "innovation+internationalization", It also explores the extensive application of biotechnology in the big health sector. The strategic
More news about: Kexing Biopharm
Aug 11, 2025, 03:00 ET NaoTrac de Brain Navi Biotechnology realiza las primeras cirugías en España
content:https://www.prnewswire.com/es/comunicados-de-prensa/naotrac-de-brain-navi-biotechnology-realiza-las-primeras-cirugias-en-espana-302524987.html
More news about: Brain Navi Biotechnology Co., Ltd.
Aug 11, 2025, 03:00 ET AMI Pharm Advances AYP-101 to Phase 3, Redefining Fat-Reduction Injectable drug with Patient Comfort in Focus
Aug. 11, 2025 /PRNewswire/ -- AMI Pharm, a biotechnology company focused on aesthetic and therapeutic innovations, announced today that its lead candidate, AYP-101, has entered a pivotal Phase
More news about: AMI Pharm
Aug 11, 2025, 02:30 ET DAESHIN MC Expands Hungarian Clean Technology Partnership... Targeting the European Market Through a Joint German Exhibition
level of cleanliness is essential, such as semiconductor production lines, hospital operating rooms, food processing plants, and pharmaceutical and biotechnology research facilities. Domestically, it has already been supplied to various facilities, including subway stations, international airports, nuclear
More news about: DAESHIN MC
Aug 08, 2025, 21:30 ET Anbio Biotechnology Responds to Global Outbreaks with Chikungunya Rapid Test and New 15-Minute Ultra-Fast PCR System
well-resourced and resource-limited settings, advancing global preparedness for infectious disease threats. About Anbio Biotechnology Anbio Biotechnology is a globally oriented in vitro diagnostics (IVD) company providing a broad range of solutions, including immunofluorescence, dry
More news about: Anbio Biotechnology
Aug 08, 2025, 16:00 ET Palatin Announces 1-for-50 Reverse Stock Split
complete clinical trials and submit applications for regulatory approvals, products developed by competing pharmaceutical, biopharmaceutical and biotechnology companies, commercial acceptance of Palatin's products, and other factors discussed in Palatin's periodic filings with the Securities and Exchange
More news about: Palatin Technologies, Inc.
Aug 08, 2025, 10:16 ET Leather for Automotive Seats Market to Surpass USD 69.1 Billion by 2031, Driven by Soaring Demand for Luxury and Electric Vehicles, According to New Report by The Insight Partners
syndicated and consulting research services. We specialize in semiconductor and electronics, aerospace and defense, automotive and transportation, biotechnology, healthcare IT, manufacturing and construction, medical devices, technology, media and telecommunications, and chemicals and materials. Contact
More news about: The Insight Partners
Aug 08, 2025, 10:01 ET Transparent Ceramics Market to Reach USD 768.03 Million by 2031, Driven by Demand from Defense, Electronics, and Optics Sectors | The Insight Partners
syndicated and consulting research services. We specialize in semiconductor and electronics, aerospace and defense, automotive and transportation, biotechnology, healthcare IT, manufacturing and construction, medical devices, technology, media and telecommunications, and chemicals and materials. Contact
More news about: The Insight Partners
Aug 08, 2025, 09:15 ET Anixa Biosciences Announces Dr. Robert Wenham will speak about Immunotherapy in surviving Ovarian Cancer at the 13th Annual Ovarcoming Cancer Conference
Anixa Biosciences, Inc. ("Anixa" or the "Company") (NASDAQ: ANIX), a biotechnology company focused on the treatment and prevention of cancer, today announced Dr. Robert Wenham, Chair of the Gynecologic
More news about: Anixa Biosciences, Inc.
Aug 08, 2025, 09:05 ET Oncolytics Biotech® Reports Second Quarter Financial Results and Details Clinical Program Plans for Pelareorep
$ 24,850 About Oncolytics Biotech Inc. Oncolytics is a clinical-stage biotechnology company developing pelareorep, an intravenously delivered immunotherapeutic agent. Pelareorep has demonstrated promising results in multiple first-line
More news about: Oncolytics Biotech® Inc.
Aug 08, 2025, 09:00 ET Oncolytics Biotech® Announces Voluntary Delisting from the Toronto Stock Exchange
not required under Section 720(b) of the TSX Company Manual. About Oncolytics Biotech Inc. Oncolytics is a clinical-stage biotechnology company developing pelareorep, an intravenously delivered immunotherapeutic agent. Pelareorep has demonstrated promising results in multiple first-line
More news about: Oncolytics Biotech® Inc.
Aug 08, 2025, 08:30 ET GenScript Unveils New Global Identity: "Scripting Possibilities" to Power the Future of Biotechnology
regions At a time when biotechnology is advancing faster than ever—and trust, transparency, and precision are in high demand—GenScript's brand elevation is a confident signal to scientists, investors, and stakeholders worldwide. The future of biotechnology is not written yet. GenScript
More news about: GenScript Biotech Corporation
Aug 08, 2025, 07:45 ET Heron Therapeutics Announces Comprehensive Capital Restructuring to Support Growth and Extend Maturity Profile
Aug. 8, 2025 Heron Therapeutics, Inc. (Nasdaq: HRTX) ("Heron" or the "Company"), a commercial-stage biotechnology company, today announced the completion of a comprehensive capital restructuring designed to enhance the Company's financial flexibility, reduce
More news about: Heron Therapeutics, Inc.